Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA new PubMed-derived publication citation (about an indirect comparison of entrectinib vs. crizotinib in Asian ROS1-positive NSCLC patients) has been added to the study’s publications list. The page’s site release/version label has been updated from one revision to another.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded a publication reference: Doebele RC et al., 'Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC' (J Comp Eff Res. 2021 Dec;10(17):1271-1282) with an Erratum in 2022. The Revision has been updated from v3.5.0 to v3.5.2 to reflect the erratum.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedPadua, Veneto, Italy, 35128 was replaced with Padova, Veneto, Italy, 35128 in the locations list. Padova, Veneto, Italy, 35128 has been added to the locations.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Naples, Campania, Italy, 80131 to the locations and removed Napoli, Campania, Italy, 80131 (city name updated from Napoli to Naples).SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision entry (v3.4.3, March 2026) was added and the prior revision (v3.4.2, January 2026) was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; this seems to be a minor backend/UI update with no substantive changes to trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.